FFAR2 and Behcet disease: The anti-inflammatory effect of butyrate was greater in the BD patients, so the authors analyzed the butyrate receptor expression in both groups and found that the mRNA levels of the lipopolysaccharide-induced free fatty acid receptor 2 in the PBMCs were higher of the BD patients than those of the healthy controls.